Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,613 | -21,816 | -12,500 | -3,597 | -15,671 |
| Depreciation Amortization | 28,115 | 20,989 | 13,677 | 6,994 | 30,722 |
| Income taxes - deferred | -1,577 | 1,826 | N/A | 103 | -5,364 |
| Accounts receivable | 17,651 | 30,367 | 27,248 | 15,612 | 7,139 |
| Accounts payable and accrued liabilities | -4,523 | -19 | 4,324 | 6,038 | -1,367 |
| Other Working Capital | 1,423 | -1,932 | 426 | 10,008 | 9,853 |
| Other Operating Activity | 9,950 | -12,314 | -23,563 | -17,796 | 34,748 |
| Operating Cash Flow | $34,426 | $17,101 | $9,612 | $17,362 | $60,060 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -8,609 | -7,617 | -6,927 | -3,575 | -5,326 |
| Net Acquisitions | -1,997 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -13 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -13 |
| Investing Cash Flow | $-12,606 | $-7,617 | $-6,927 | $-3,575 | $-5,339 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,000 | 60,000 | 60,000 | 60,000 | N/A |
| Debt Repayment | -58,527 | -48,415 | -28,000 | -15,133 | -50,478 |
| Common Stock Issued | 1,314 | 658 | 658 | N/A | 3,635 |
| Common Stock Repurchased | -10,495 | -10,495 | -10,495 | -10,495 | N/A |
| Other Financing Activity | -3,169 | -3,111 | -2,168 | -1,883 | -1,689 |
| Financing Cash Flow | $-10,877 | $-1,363 | $19,995 | $32,489 | $-48,532 |
| Exchange Rate Effect | 7,842 | 3,118 | -1,099 | -2,557 | 735 |
| Beginning Cash Position | 63,297 | 63,297 | 63,297 | 63,297 | 56,373 |
| End Cash Position | 82,082 | 74,536 | 84,878 | 107,016 | 63,297 |
| Net Cash Flow | $18,785 | $11,239 | $21,581 | $43,719 | $6,924 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,426 | 17,101 | 9,612 | 17,362 | 60,060 |
| Capital Expenditure | -8,609 | -7,617 | -6,927 | -3,575 | -5,326 |
| Free Cash Flow | 25,817 | 9,484 | 2,685 | 13,787 | 54,734 |